Limitations and Potential Improvement of Cognitive Screening Tests for Mild Cognitive Impairment

Abstract

Background: Mild cognitive impairment (MCI), an early sign of Alzheimer's Disease (AD), involves disruptions in both memory and cognition. Early and accurate detection of MCI is critical, as recently FDA approved disease modifying treatments are most effective at this stage of AD.

The paper